Literature DB >> 19782016

Hypoglycaemia: an overview.

Alex J Graveling1, Brian M Frier.   

Abstract

Hypoglycaemia is a frequent side-effect of treatment with insulin and sulfonylureas for people with diabetes, threatening potentially serious morbidity and preventing optimal glycaemic control. Fear of hypoglycaemia and development of syndromes such as impaired awareness and counterregulatory deficiency provide additional hazards for intensification of treatment. Rapid lowering of HbA1c may be potentially dangerous in type 2 diabetes because of the adverse cardiovascular effects induced by hypoglycaemia. Hypoglycaemia can disrupt many everyday activities such as driving, work performance and recreational pursuits. Measures to reduce the risk of hypoglycaemia are labour-intensive and require substantial resources.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19782016     DOI： 10.1016/j.pcd.2009.08.007

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN： 1878-0210            Impact factor:   2.459


  17 in total

1.  Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine.

Authors:  Zurab Kakabadze; Sanjeev Gupta; Daniel Brandhorst; Olle Korsgren; Ekaterine Berishvili
Journal:  Transpl Int       Date:  2010-09-06       Impact factor: 3.782

Review 2.  Type 2 diabetes mellitus in older adults: clinical considerations and management.

Authors:  Srikanth Bellary; Ioannis Kyrou; James E Brown; Clifford J Bailey
Journal:  Nat Rev Endocrinol       Date:  2021-06-25       Impact factor: 43.330

Review 3.  Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

Authors:  Brian M Frier
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

Review 4.  Cardiovascular Outcomes Trials Update: Insights from the DEVOTE Trial.

Authors:  Anika Bilal; Richard E Pratley
Journal:  Curr Diab Rep       Date:  2018-09-18       Impact factor: 4.810

5.  Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Authors:  Steven P Marso; Darren K McGuire; Bernard Zinman; Neil R Poulter; Scott S Emerson; Thomas R Pieber; Richard E Pratley; Poul-Martin Haahr; Martin Lange; Kirstine Brown-Frandsen; Alan Moses; Simon Skibsted; Kajsa Kvist; John B Buse
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

Review 6.  Update on strategies limiting iatrogenic hypoglycemia.

Authors:  Aldo Bonaventura; Fabrizio Montecucco; Franco Dallegri
Journal:  Endocr Connect       Date:  2015-06-22       Impact factor: 3.335

7.  Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective.

Authors:  Stewart B Harris; Kamlesh Khunti; Mona Landin-Olsson; Claus B Galbo-Jørgensen; Mette Bøgelund; Barrie Chubb; Jens Gundgaard; Marc Evans
Journal:  Patient Prefer Adherence       Date:  2013-09-16       Impact factor: 2.711

8.  Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Authors:  Berit Inkster; Renata L Riha; Liesbeth Van Look; Rachel Williamson; Stela McLachlan; Brian M Frier; Mark W J Strachan; Jackie F Price; Rebecca M Reynolds
Journal:  Diabetes Care       Date:  2013-10-02       Impact factor: 19.112

Review 9.  Patient safety and minimizing risk with insulin administration - role of insulin degludec.

Authors:  Myint M Aye; Stephen L Atkin
Journal:  Drug Healthc Patient Saf       Date:  2014-04-30

10.  Insulin degludec versus insulin glargine in type 1 and type 2 diabetes mellitus: a meta-analysis of endpoints in phase 3a trials.

Authors:  Jiten Vora; Torsten Christensen; Azhar Rana; Steve C Bain
Journal:  Diabetes Ther       Date:  2014-08-01       Impact factor: 2.945
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.